About Matt:

Dr. Matthew Dawson attended medical school at The University of Kentucky before completing his residency in emergency medicine at The University of Utah, where he served as both chief resident and fellow. After practicing medicine and serving as an associate professor at the University of Kentucky for seven years, Dr. Dawson developed a deep interest in genomics and epigenetics, realizing their potential to revolutionize our understanding of health and longevity.

As the CEO of TruDiagnostic, Dr. Dawson leads the company’s mission to advance the science of epigenetics and provide groundbreaking insights into aging and disease prevention. His dedication to optimizing human performance, which began with his personal focus on fitness and nutrition, has evolved into a professional pursuit of harnessing epigenetic data to extend health span and improve overall well-being. Under his leadership, TruDiagnostic is at the forefront of epigenetic testing and research, empowering individuals and researchers with actionable information about biological aging, disease susceptibility, and personalized health strategies. Dr. Dawson’s passion for using cutting-edge science to impact lives is evident in his efforts to bridge the gap between epigenetic research and practical healthcare applications. He has trained physicians and healthcare providers in the importance of epigenetic markers, ensuring that TruDiagnostic’s work continues to push the boundaries of what’s possible in preventive health. He regularly shares insights through public speaking and educational platforms, advocating for the role of epigenetics in reshaping healthcare.

Links:

Learn more about TruDiagnostic at trudiagnostic.com

Download the Hollis app

Follow TruDiagnostic on Instagram (@trudiagnosticofficial), X (@trudiagnostic), and LinkedIn (TruDiagnostic)